KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Net Income (2016 - 2025)

Teladoc Health (TDOC) has disclosed Net Income for 12 consecutive years, with -$25.1 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 48.06% to -$25.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$200.3 million through Dec 2025, up 80.0% year-over-year, with the annual reading at -$200.3 million for FY2025, 79.99% up from the prior year.
  • Net Income hit -$25.1 million in Q4 2025 for Teladoc Health, up from -$49.5 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$11.0 million in Q4 2021 to a low of -$6.7 billion in Q1 2022.
  • Historically, Net Income has averaged -$775.5 million across 5 years, with a median of -$71.3 million in 2022.
  • Biggest five-year swings in Net Income: tumbled 34584.57% in 2022 and later skyrocketed 99.24% in 2023.
  • Year by year, Net Income stood at -$11.0 million in 2021, then crashed by 34584.57% to -$3.8 billion in 2022, then surged by 99.24% to -$28.9 million in 2023, then tumbled by 67.3% to -$48.4 million in 2024, then surged by 48.06% to -$25.1 million in 2025.
  • Business Quant data shows Net Income for TDOC at -$25.1 million in Q4 2025, -$49.5 million in Q3 2025, and -$32.6 million in Q2 2025.